Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis

Journal of Vascular Surgery

Volumn 54, Issue 6 SUPPL., 2011, Pages 26S-32S

  Muñoz Torrero, Juan Francisco Sanchez ^a   Bounameaux, Henri ^b   Pedrajas, José María ^c   Lorenzo, Alicia ^d   Rubio, Silvino ^e   Kearon, Clive ^f   Hernández, Luís ^g   Monreal, Manuel ^h  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e Hospital de Cabuees   (Spain)

^f MCMASTER UNIVERSITY   (Canada)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; DISEASE COURSE; FATALITY; FEMALE; HUMAN; LEG THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 82455210234     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.05.114     Document Type: Article

References (17)

1. C. Kearon, S. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 301 2008 454 545S
2. C.I. Lagerstedt, C.G. Olsson, B.O. Fagher, B.W. Oqvist, and U. Albrechtsson Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis Lancet 2 1985 515 518 (Pubitemid 15236478)
3. R. Hull, T. Delmore, E. Genton, J. Hirsh, M. Gent, and D. Sackett Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis N Engl J Med 301 1979 855 858 (Pubitemid 10165871)
4. M.N. Levine, J. Hirsh, M. Gent, A.G. Turpie, J. Weitz, and J. Ginsberg Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis Thromb Haemost 74 1995 606 611
5. C. Kearon, J.S. Ginsberg, M.J. Kovacs, D.R. Anderson, P. Wells, J.A. Julian Extended Low-Intensity Anticoagulation for Thromboembolism Investigators Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism N Engl J Med 349 2003 631 639 (Pubitemid 36975995)
6. P.M. Ridker, S.Z. Goldhaber, E. Danielson, Y. Rosenberg, C.S. Eby, S.R. Deitcher PREVENT Investigators Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 2003 1425 1434 (Pubitemid 36407171)
7. G. Piazza, A. Seddighzadeh, and S.Z. Goldhaber Deep-vein thrombosis in the elderly Clin Appl Thromb Hemost 14 2008 393 398
8. F.A. Spencer, J.M. Gore, D. Lessard, C. Emery, L. Pacifico, and G. Reed Venous thromboembolism in the elderly A community-based perspective Thromb Haemost 100 2008 780 788
9. J.I. Arcelus, J.A. Caprini, M. Monreal, C. Suárez, and J. González-Fajardo The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients J Vasc Surg 38 2003 916 922 (Pubitemid 37409622)
10. S. Laporte, P. Mismetti, H. Découssus, F. Uresandi, R. Otero, J.L. Lobo RIETE investigators Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism; findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry Circulation 117 2008 1711 1716 (Pubitemid 351482603)
11. J. Trujillo-Santos, J.A. Nieto, G. Tiberio, A. Piccioli, P. di Micco, P. Prandoni RIETE Registry Predicting recurrences or major bleeding in cancer patients with venous thromboembolism Findings from the RIETE registry Thromb Haemost 100 2000 435 439
12. L. López-Jiménez, M. Montero, J.A. González-Fajardo, J.I. Arcelus, C. Suárez, J.L. Lobo RIETE investigators Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE) Haematologica 96 2006 1046 1051 (Pubitemid 44204770)
13. B. Vasco, J.C. Villalba, L. Lopez-Jimenez, C. Falgá, J. Montes, J. Trujillo-Santos RIETE Investigators Venous thromboembolism in nonagenarians Findings from the RIETE Registry Thromb Haemost 101 2009 1112 1118
14. L.A. Linkins, P.T. Choi, and J.D. Douketis Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis Ann Intern Med 139 2003 893 900
15. C. Kearon, J.S. Ginsberg, J.A. Julian, J. Douketis, S. Solymoss, P. Ockelford Fixed-dose heparin (FIDO) Investigators Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism JAMA 296 2006 935 942 (Pubitemid 44285370)
16. S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, H. Eriksson RE-COVER Study group Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
17. M. Carrier, G. Le Gal, P.S. Wells, and M.A. Rodger Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism Ann Intern Med 152 2010 578 589